Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Neurosci ; 36(17): 4888-94, 2016 04 27.
Artículo en Inglés | MEDLINE | ID: mdl-27122043

RESUMEN

UNLABELLED: Dendritic spines are a morphological feature of the majority of excitatory synapses in the mammalian neocortex and are motile structures with shapes and lifetimes that change throughout development. Proper cortical development and function, including cortical contributions to learning and memory formation, require appropriate experience-dependent dendritic spine remodeling. Dendritic spine abnormalities have been reported for many neurodevelopmental disorders, including Angelman syndrome (AS), which is caused by the loss of the maternally inherited UBE3A allele (encoding ubiquitin protein ligase E3A). Prior studies revealed that UBE3A protein loss leads to reductions in dendritic spine density and diminished excitatory synaptic transmission. However, the decrease in spine density could come from either a reduction in spine formation or an increase in spine elimination. Here, we used acute and longitudinal in vivo two-photon microscopy to investigate developmental and experience-dependent changes in the numbers, dynamics, and morphology of layer 5 pyramidal neuron apical dendritic spines in the primary visual cortex of control and AS model mice (Ube3a(m-/p+) mice). We found that neurons in AS model mice undergo a greater elimination of dendritic spines than wild-type mice during the end of the first postnatal month. However, when raised in darkness, spine density and dynamics were indistinguishable between control and AS model mice, which indicates that decreased spine density in AS model mice reflects impaired experience-driven spine maintenance. Our data thus demonstrate an experience-dependent anatomical substrate by which the loss of UBE3A reduces dendritic spine density and disrupts cortical circuitry. SIGNIFICANCE STATEMENT: Reduced dendritic spine densities are common in the neurodevelopmental disorder Angelman syndrome (AS). Because prior reports were based on postmortem tissue, it was unknown whether this anatomical deficit arises from decreased spine formation and/or increased spine elimination. Here, we used in vivo two-photon imaging to track spines over multiple days in a mouse model of AS. We found that spine formation is normal, but experience-dependent spine maintenance is reduced in the visual cortex of AS model mice. Our data pinpoint the anatomical process underlying the loss of dendritic spines, which can account for the decreased excitatory synaptic connectivity associated with AS. Therefore, normalizing spine maintenance is a potential therapeutic strategy.


Asunto(s)
Síndrome de Angelman/genética , Dendritas/metabolismo , Espinas Dendríticas/fisiología , Plasticidad Neuronal/fisiología , Corteza Visual/metabolismo , Animales , Modelos Animales de Enfermedad , Femenino , Genotipo , Proteínas Fluorescentes Verdes/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Neocórtex/metabolismo , Neuronas/fisiología , Células Piramidales/metabolismo , Sinapsis/fisiología , Ubiquitina-Proteína Ligasas/genética
2.
Am J Med Genet A ; 173(10): 2703-2709, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28816003

RESUMEN

Angelman syndrome (AS) is a neurogenetic disorder characterized by intellectual disability, expressive speech impairment, movement disorder, epilepsy, and a happy demeanor. Children with AS are frequently reported to be poor feeders during infancy and as having gastrointestinal issues such as constipation, reflux, and abnormal food related behaviors throughout their lifetime. To assess the prevalence of gastrointestinal disorders in individuals with AS, we retrospectively analyzed medical records of 120 individuals seen at the Angelman Syndrome Clinic at Massachusetts General Hospital and 43 individuals seen at the University of North Carolina Comprehensive Angelman Clinic. The majority of patients' medical records indicated at least one symptom of gastrointestinal dysfunction, with constipation and gastroesophageal reflux disease (GERD) the most common. Other gastrointestinal issues reported were cyclic vomiting episodes, difficulty swallowing, excessive swallowing, and eosinophilic esophagitis. Upper gastrointestinal symptoms such as GERD, swallowing difficulties, cyclic vomiting, and eosinophilic esophagitis were more common in those with deletions and uniparental disomy, likely related to the involvement of multiple genes and subsequent hypotonia. The frequency of constipation is consistent among all genetic subtypes while early feeding issues appear to mainly affect those with deletions. Caregivers and healthcare providers should be aware of the high prevalence of these issues, as proper treatment may improve not only gastrointestinal dysfunction but also sleep and behavioral issues.


Asunto(s)
Síndrome de Angelman/complicaciones , Enfermedades Gastrointestinales/epidemiología , Adolescente , Adulto , Síndrome de Angelman/fisiopatología , Niño , Preescolar , Femenino , Enfermedades Gastrointestinales/etiología , Enfermedades Gastrointestinales/patología , Humanos , Lactante , Masculino , Massachusetts/epidemiología , Prevalencia , Pronóstico , Estudios Retrospectivos , Adulto Joven
3.
J Neurosci ; 33(18): 7762-9, 2013 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-23637168

RESUMEN

NMDA receptors (NMDARs) are required for experience-driven plasticity during formative periods of brain development and are critical for neurotransmission throughout postnatal life. Most NMDAR functions have been ascribed to postsynaptic sites of action, but there is now an appreciation that presynaptic NMDARs (preNMDARs) can modulate neurotransmitter release in many brain regions, including the neocortex. Despite these advances, the cellular mechanisms by which preNMDARs can affect neurotransmitter release are largely unknown. Here we interrogated preNMDAR functions pharmacologically to determine how these receptors promote spontaneous neurotransmitter release in mouse primary visual cortex. Our results provide three new insights into the mechanisms by which preNMDARs can function. First, preNMDARs can enhance spontaneous neurotransmitter release tonically with minimal extracellular Ca(2+) or with major sources of intracellular Ca(2+) blocked. Second, lowering extracellular Na(+) levels reduces the contribution of preNMDARs to spontaneous transmitter release significantly. Third, preNMDAR enhance transmitter release in part through protein kinase C signaling. These data demonstrate that preNMDARs can act through novel pathways to promote neurotransmitter release in the absence of action potentials.


Asunto(s)
Neuronas/citología , Neurotransmisores/metabolismo , Terminales Presinápticos/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Sinapsis/metabolismo , 2-Amino-5-fosfonovalerato/farmacología , Animales , Animales Recién Nacidos , Calcio/metabolismo , Corteza Cerebral/citología , Relación Dosis-Respuesta a Droga , Estimulación Eléctrica , Inhibidores Enzimáticos/farmacología , Antagonistas de Aminoácidos Excitadores/farmacología , Potenciales Postsinápticos Excitadores/efectos de los fármacos , Potenciales Postsinápticos Excitadores/fisiología , Femenino , Técnicas In Vitro , Masculino , Ratones , Ratones Endogámicos C57BL , Técnicas de Placa-Clamp , Pirimidinas/farmacología , Bloqueadores de los Canales de Sodio/farmacología , Cloruro de Sodio/farmacología , Tetrodotoxina/farmacología
4.
J Physiol ; 590(22): 5749-64, 2012 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-22988142

RESUMEN

Glycine receptors (GlyRs) are found in most areas of the brain, and their dysfunction can cause severe neurological disorders. While traditionally thought of as inhibitory receptors, presynaptic-acting GlyRs (preGlyRs) can also facilitate glutamate release under certain circumstances, although the underlying molecular mechanisms are unknown. In the current study, we sought to better understand the role of GlyRs in the facilitation of excitatory neurotransmitter release in mouse visual cortex. Using whole-cell recordings, we found that preGlyRs facilitate glutamate release in developing, but not adult, visual cortex. The glycinergic enhancement of neurotransmitter release in early development depends on the high intracellular to extracellular Cl(-) gradient maintained by the Na(+)-K(+)-2Cl(-) cotransporter and requires Ca(2+) entry through voltage-gated Ca(2+) channels. The glycine transporter 1, localized to glial cells, regulates extracellular glycine concentration and the activation of these preGlyRs. Our findings demonstrate a developmentally regulated mechanism for controlling excitatory neurotransmitter release in the neocortex.


Asunto(s)
Potenciales Postsinápticos Excitadores , Neurotransmisores/metabolismo , Receptores de Glicina/metabolismo , Corteza Visual/fisiología , Animales , Calcio/metabolismo , Canales de Calcio/metabolismo , Cloro/metabolismo , Exocitosis , Glicina/metabolismo , Proteínas de Transporte de Glicina en la Membrana Plasmática/metabolismo , Ratones , Ratones Endogámicos C57BL , Neuroglía/metabolismo , Células Piramidales/metabolismo , Células Piramidales/fisiología , Simportadores de Cloruro de Sodio-Potasio/metabolismo , Sinapsis/fisiología , Sinapsis/ultraestructura , Corteza Visual/crecimiento & desarrollo
5.
Neuron ; 76(2): 396-409, 2012 Oct 18.
Artículo en Inglés | MEDLINE | ID: mdl-23083741

RESUMEN

Adhesive contact between pre- and postsynaptic neurons initiates synapse formation during brain development and provides a natural means of transsynaptic signaling. Numerous adhesion molecules and their role during synapse development have been described in detail. However, once established, the mechanisms of adhesive disassembly and its function in regulating synaptic transmission have been unclear. Here, we report that synaptic activity induces acute proteolytic cleavage of neuroligin-1 (NLG1), a postsynaptic adhesion molecule at glutamatergic synapses. NLG1 cleavage is triggered by NMDA receptor activation, requires Ca2+ /calmodulin-dependent protein kinase, and is mediated by proteolytic activity of matrix metalloprotease 9 (MMP9). Cleavage of NLG1 occurs at single activated spines, is regulated by neural activity in vivo, and causes rapid destabilization of its presynaptic partner neurexin-1ß (NRX1ß). In turn, NLG1 cleavage depresses synaptic transmission by abruptly reducing presynaptic release probability. Thus, local proteolytic control of synaptic adhesion tunes synaptic transmission during brain development and plasticity.


Asunto(s)
Moléculas de Adhesión Celular Neuronal/metabolismo , Hipocampo/citología , Neuronas/fisiología , Transducción de Señal/fisiología , Transmisión Sináptica/fisiología , Animales , Animales Recién Nacidos , Biotinilación , Proteínas de Unión al Calcio , Moléculas de Adhesión Celular Neuronal/genética , Células Cultivadas , Corteza Cerebral/citología , Chlorocebus aethiops , Adaptación a la Oscuridad/genética , Dendritas/metabolismo , Dendritas/ultraestructura , Modelos Animales de Enfermedad , Estimulación Eléctrica , Electroporación , Inhibidores Enzimáticos/farmacología , Fármacos actuantes sobre Aminoácidos Excitadores/farmacología , Potenciales Postsinápticos Excitadores/efectos de los fármacos , Potenciales Postsinápticos Excitadores/genética , Femenino , Ácido Glutámico/farmacología , Proteínas Fluorescentes Verdes/genética , Proteínas Luminiscentes/genética , Proteínas Luminiscentes/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Microscopía Confocal , Agonistas Muscarínicos/toxicidad , Mutación/genética , Moléculas de Adhesión de Célula Nerviosa/metabolismo , Neuronas/citología , Neuronas/efectos de los fármacos , Técnicas de Cultivo de Órganos , Técnicas de Placa-Clamp , Fotones , Pilocarpina/toxicidad , Lectinas de Plantas/genética , Lectinas de Plantas/metabolismo , Cloruro de Potasio/farmacología , Embarazo , Compuestos de Piridinio/metabolismo , Compuestos de Amonio Cuaternario/metabolismo , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética , Estado Epiléptico/inducido químicamente , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/genética , Treonina/genética , Treonina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA